Delivery Order SPE2DB24D9238-SPE2DB25FDRAL
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,174.74 on August 4, 2025, for the supply of OMIDRIA 1-0.3% vials (4ml). This firm fixed-price delivery order, issued without a set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries an ultimate completion date of August 25, 2025. The award represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Omidria 1-0.3% Vial 4ML. The delivery order has a potential value of $5,753.55 and a completion date of December 11, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its place of performance in Park Ridge, Illinois. As a woman-owned small business and pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,737.97, is for the delivery of OMIDRIA 1-0.3% vial, 4 mL, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,566.32 contract is for the delivery of OMIDRIA 1-0.3% VIAL 4ML, a medical supply, with a completion date of June 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders...
- This contract award, valued at $4,983.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product OMIDRIA 1-0.3% VIAL 4ML, with an ultimate completion date of July 22, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $9,889.86 from the Defense Logistics Agency's Medical Supply Chain division on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,034.56 by the Defense Logistics Agency's Medical Supply Chain division on September 8, 2025. The delivery order, which carries no set-aside designation, is expected to be completed by September 10, 2025, and represents a task order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. This delivery order, which carries no set-aside designation, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,679.96 by the Defense Logistics Agency on September 2, 2025, with completion targeted for September 3, 2025. This delivery order, which carries no set-aside designation, falls under the company's larger $499.999 billion Indefinite Delivery Contract with DLA's SPE2DB program, valid through November 2026. The delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $11,591.36 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 28, 2025, represents a discrete purchase under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRALDelivery Order
The Defense Logistics Agency awarded a $2,391.60 delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for Omidria 1-0.3% vial 4ML, a pharmaceutical product used during ophthalmic surgery. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. The company has been registered in the System for Award Management since 2001 and specializes in supplying comprehensive pharmaceutical products to federal agencies. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026 under the SPE2DB program. This umbrella contract enables the agency to procure a broad range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency to provide direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/9/25 |